At Transdermal Diagnostics, we are pioneering the development of a wearable platform to improve the prevention, diagnosis, and management of chronic conditions, starting with diabetes. We aim to catalyze a paradigm shift towards better patient care and enhanced quality of life. Our game-changing technology is a non-invasive, disposable smart patch enabling real-time co-monitoring of health-related biomarkers and metabolites. Currently, we are developing the world's first 100% needle-free (and pain-free) device that empowers people with diabetes, prediabetes and obesity to know, learn and act for an improved lifestyle using data based on personalized biological insights.
Employees: 1-10
Total raised: $920.9K
Founded date: 2021
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.09.2022 | Seed | $920.9K | - |